2020

1. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

   Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

2. Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes

   Human Mutation, Vol. 41, Núm. 7, pp. 1308-1320